News

Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales18.3411.27 63 52.7137.66 40 OPM %12.3211.62 -14.107.33 - PBDT2.271.55 46 8.133.46 135 PBT2.021.30 55 7.122.72 162 NP1.301.05 24 4.502.11 113 Powered by Capital Market - Live News

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Net profit of Eiko Lifesciences rose 239.29% to Rs 0.95 crore in the quarter ended December 2025 as against Rs 0.28 crore during the previous quarter ended December 2024. Sales rose 38.49% to Rs 9.57 crore in the quarter ended December 2025 as against Rs 6.91 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales9.576.91 38 OPM %9.096.51 - PBDT1.390.53 162 PBT1.240.38 226 NP0.950.28 239 Powered by Capital Market - Live News

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live News

Eiko Lifesciences announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 7 January 2026.Powered by Capital Market - Live News